Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach

scientific article published on January 1, 2003

Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1053067164
P356DOI10.1038/SJ.TPJ.6500207
P953full work available at URLhttps://www.nature.com/articles/6500207
https://www.nature.com/articles/6500207.pdf
P698PubMed publication ID14610520
P5875ResearchGate publication ID9014252

P2093author name stringL. Suter
S. Albertini
M. Haiker
M. C. De Vera
P2860cites workJournal of neural transmission. SupplementumQ27711624
A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulationQ28263452
Can molecular mechanisms of biological processes be extracted from expression profiles? Case study: endothelial contribution to tumor-induced angiogenesisQ34464693
Toxicogenomics; transcript profiling and potential application to chemical allergyQ34646399
Drug Metabolism and DispositionQ1261140
Molecular PharmacologyQ1943386
5-Hydroxytryptamine receptor subtypes in vertebrates and invertebratesQ34662457
Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotionQ36831567
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.Q38298172
Central distribution and function of 5-HT6 receptor subtype in the rat brainQ38337647
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotidesQ38363328
Prediction of compound signature using high density gene expression profilingQ38456725
Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell lineQ40696953
Antibacterial-induced hepatotoxicity. Incidence, prevention and managementQ41156683
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicityQ43588948
RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarraysQ43601218
A Link between cholesterol levels and phenobarbital induction of cytochromes P450.Q43887283
Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarrayQ44054397
Modulation of gene and protein expression by carbon tetrachloride in the rat liverQ44129138
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicityQ44552108
Cloning and sequencing of a novel rat cytochrome P450 2B-encoding geneQ48087188
Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.Q51570654
Toxicogenomics: the new frontier in risk analysis.Q52037926
Cytochrome P-450 isozyme 1 from phenobarbital-induced rat liver: purification, characterization, and interactions with metyrapone and cytochrome b5Q58483899
Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibioticQ68505264
Toxicogenomics and toxic tortsQ74485233
Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liverQ77217429
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectgeneticsQ7162
pharmacologyQ128406
molecular medicineQ3523816
P304page(s)320-334
P577publication date2003-01-01
P1433published inThe Pharmacogenomics JournalQ10534704
P1476titleEffect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach
P478volume3

Reverse relations

cites work (P2860)
Q38025961A decade of toxicogenomic research and its contribution to toxicological science
Q38066244An omics strategy for discovering pulmonary biomarkers potentially relevant to the evaluation of tobacco products
Q24813403Discriminating different classes of toxicants by transcript profiling
Q57477472Establishment of a novel safety assessment method for vaccine adjuvant development
Q36572578Gene expression profiling for pharmaceutical safety assessment
Q45151649Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development
Q43291838Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis
Q37658719Toxicogenomics and cross-species biomarker discovery: applications in drug discovery and safety assessment